Delivery Order SPE2DE21D0007-SPE2D624F7V4V
Award Date 6/3/24
Potential Completion Date 6/25/24
Potential Value $1.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,072.88, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc. for the delivery of ANTI-A BIOCLONE 15X10ML medical supplies. The contract was awarded as a fixed price with economic price adjustment delivery order, without any set-aside designation. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including reagents, test kits, and clinical...
- This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the delivery of 4567190755 ANTI-B BIOCLONE 15X10ML, a critical medical diagnostic product. It is a fixed price delivery order with economic price adjustment, with a completion date of February 12, 2025. No set-aside designation was used, indicating open competition....
- This federal contract award, with ID SPE2DE21D0007|SPE2D624F5M1P, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,746.00 fixed-price with economic price adjustment delivery order is for the supply of 4564636234 ! ANTI-A BIOCLONE 15X10ML products. The contract has a completion date of May 20, 2024. Ortho-Clinical Diagnostics holds several...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,037.23 firm fixed price delivery order is for the supply of 4566514555 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The ultimate completion date for this contract is November 26, 2024. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and testing services to federal agencies...
- This federal contract award, with ID SPE2DE21D0007|SPE2D625F6100, was issued by the Defense Logistics Agency Troop Support Medical, which is part of the Department of Defense. The $1,832.54 fixed price with economic price adjustment delivery order was awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the procurement of 4566126643 ANTI-B BIOCLONE 15X10ML. The contract does not have a set-aside designation and is scheduled for completion by November 7,...
- This federal contract award, SPE2DE21D0007|SPE2D625F62NR, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $2,111.62 fixed-price delivery order with economic price adjustment is for the supply of "ANTI-A BIOCLONE 15X10ML" medical products. The contract has a period of performance ending on February 10, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified...
- This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,832.54 contract is for the delivery of 4,565,172,008 units of an anti-B bioclone product. The contract has a period of performance through July 19, 2024 and does not have a set-aside designation. Ortho-Clinical Diagnostics is a for-profit company that has provided medical equipment, reagents, and testing services to various federal...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of anti-A bioclone 15x10ml. The contract was awarded by the Medical Supply Chain, a component of the Defense agency, and has a ceiling value of $1,832.54. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating...